LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma
Clinical trial NCT04577807 · COMPLETED
Trial details
- NCT number
- NCT04577807
- Sponsor
- Istari Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2024-11-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.